Opinion|Videos|November 21, 2024
Telehealth and Research Strides for Young Patients
Author(s)Lisa Swanson, MD, FAAD
Key Takeaways
- Telemedicine and digital health tools enable remote consultations, improving management and follow-up care for pediatric vitiligo patients by reducing the need for frequent in-person visits.
- Emerging research aims to understand vitiligo pathogenesis, focusing on immune modulation, genetic factors, and novel drug targets to develop therapies that halt or slow disease progression.
Lisa Swanson, MD, discusses how telemedicine and digital health tools can aid in the management and follow-up care of pediatric patients with vitiligo by enabling remote monitoring, improving access to specialists, and facilitating patient engagement, while emerging research into vitiligo treatments may focus on developing therapies to halt or slow the progression of this autoimmune skin condition.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How do you see advancements in telemedicine or digital health tools aiding in the management and follow-up care of pediatric vitiligo patients?
- In terms of future treatments, what emerging research might focus on halting or slowing the progression of the disease?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Reviewing Type 2 Inflammation Through a Different Lens
3
Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott
4
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
5
